Ma Y, Chen Q, Zhang Y, Xue J, et al. Pharmacokinetics, safety, tolerability, and feasibility of apatinib in combination with gefitinib in stage IIIB-IV EGFR-mutated non-squamous NSCLC: a drug-drug interaction study. Cancer Chemother Pharmacol 2023;92:411-418.
PMID: 37518060